Related Experiment Video
Updated: Jan 13, 2026

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
Malicious poisoning of a canine with the neuromuscular blocking agent rocuronium: a case report with postmortem
John P Buchweitz1,2, Justin A Zyskowski1, Kevin Cajigas3
1Michigan State University Veterinary Diagnostic Laboratory, Michigan State University College of Veterinary Medicine, Lansing, MI 48910, United States.
Abstract:
Rocuronium bromide is a non-depolarizing neuromuscular blocking agent (NMBA) commonly used in anesthesia for its rapid onset and intermediate duration of action. While its therapeutic use has been well-documented in humans and experimentally in dogs, this report describes the first known case of its malicious use in the fatal intoxication of a canine. Herein we describe the case of a six-year-old male Plott Hound found deceased under suspicious circumstances. Postmortem investigation revealed focal hemorrhages near potential injection sites, and toxicological analysis via liquid chromatography-tandem mass spectrometry confirmed the presence of rocuronium in muscle tissue, heart blood, and urine. The dog had no surgical history or indication for anesthesia. However, rocuronium concentrations mirrored those seen in anesthetized human patients under ventilatory support. The owner, a licensed pharmacist, was suspected of drug theft and aggravated animal abuse. This case highlights the lethality of NMBAs when misused outside of the clinical setting and further underscores a collaborative, multi-institutional, multidisciplinary approach to veterinary forensic investigations.
More Related Videos
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Skeletal Muscle Relaxants: Therapeutic Uses
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...

